The Substance Abuse and Mental Health Services Administration (SAMHSA) today published a Final Notice of Revisions to its Mandatory Guidelines for Federal Workplace Drug Testing Programs (Guidelines). The Guidelines establish the scientific and technical guidelines for the Federal workplace drug testing programs and establish standards for certification of laboratories engaged in drug testing for Federal agencies by addressing the collection and testing of urine specimens, the requirements for the certification of Instrumented Initial Test Facilities (IITFs), and the role of and standards for collectors and Medical Review Officers (MROs).
Date Added: 11/25/08